Yun Hsia MD, MS , Cheng-Yung Lee MD , Mei-Chi Tsui MD , Shih-Wen Wang MD , Chien-Jung Huang MD , I-Hsin Ma MD, MS , Kuo-Chi Hung MD , Muh-Shy Chen MD, PhD , Zih-Wei Yang MD , Bo-Da Huang MD , Ting-Chieh Ko MD , Tzyy-Chang Ho MD
{"title":"Long-Shaft Vitrectomy Probe for Vitreoretinal Diseases in Highly Myopic Eyes: A Randomized Controlled Trial","authors":"Yun Hsia MD, MS , Cheng-Yung Lee MD , Mei-Chi Tsui MD , Shih-Wen Wang MD , Chien-Jung Huang MD , I-Hsin Ma MD, MS , Kuo-Chi Hung MD , Muh-Shy Chen MD, PhD , Zih-Wei Yang MD , Bo-Da Huang MD , Ting-Chieh Ko MD , Tzyy-Chang Ho MD","doi":"10.1016/j.xops.2025.100824","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the safety and efficacy of a long-shaft vitrectomy probe in highly myopic eyes undergoing pars plana vitrectomy.</div></div><div><h3>Design</h3><div>A randomized controlled trial.</div></div><div><h3>Subjects</h3><div>Highly myopic eyes (axial length [AL] >26 mm) with epiretinal membrane (ERM), myopic tractional maculopathy, and retinal detachment.</div></div><div><h3>Methods</h3><div>The enrolled eyes were randomly assigned to a study group (UltraVit 25 Ga, 31.75 mm, Alcon) and a control group (UltraVit 25 Ga+, 27 mm, Alcon). Stratified randomization was performed to balance the proportion of eyes with AL >28 mm between groups.</div></div><div><h3>Main Outcome Measures</h3><div>Trocar removal rate and core vitrectomy time were assessed as primary outcomes, and instrument bending as a secondary outcome. Anatomical and visual outcomes and complications were documented for 6 months. Subgroup analysis was performed to compare the eyes with AL >28 mm to those without.</div></div><div><h3>Results</h3><div>We included 86 patients with a mean age of 60.7 ± 9.6 years and an AL of 29.15 ± 2.14 mm. Two groups had comparable core vitrectomy times (−0.5 minutes, <em>P</em> = 0.172). The study group had a lower trocar removal rate (5% vs. 67%, <em>P</em> < 0.001) but a higher instrument bending rate (36% vs. 14%, <em>P</em> = 0.036), particularly in eyes with AL >28 mm. In eyes with AL >28 mm, the standard vitrectomy probe faced a significantly greater difficulty in cortical vitreous removal, internal limiting membrane (ILM) trimming, or posterior vitreous detachment induction compared with the long-shaft vitrectomy (<em>P</em> < 0.001). At 6 months, significant visual improvement (logarithm of the minimum angle of resolution) and anatomical success were achieved (study: −0.22, 95%; control: −0.24, 88%). Eyes with ERM in the study group, not the controls, had significant visual improvement (−0.21, <em>P</em> = 0.02 vs. −0.09, <em>P</em> = 0.34).</div></div><div><h3>Conclusions</h3><div>The long-shaft vitrectomy probe is safe and efficient, especially in highly myopic eyes with AL >28 mm, despite a higher instrument bending rate. It provides improved access to the posterior pole, allowing for delicate removal of adherent cortical vitreous and trimming of ILM flaps. Addressing increased instrument bending due to the sleeveless design is important for future design.</div></div><div><h3>Financial Disclosure(s)</h3><div>The author(s) have no proprietary or commercial interest in any materials discussed in this article.</div></div>","PeriodicalId":74363,"journal":{"name":"Ophthalmology science","volume":"5 5","pages":"Article 100824"},"PeriodicalIF":3.2000,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology science","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666914525001228","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To evaluate the safety and efficacy of a long-shaft vitrectomy probe in highly myopic eyes undergoing pars plana vitrectomy.
Design
A randomized controlled trial.
Subjects
Highly myopic eyes (axial length [AL] >26 mm) with epiretinal membrane (ERM), myopic tractional maculopathy, and retinal detachment.
Methods
The enrolled eyes were randomly assigned to a study group (UltraVit 25 Ga, 31.75 mm, Alcon) and a control group (UltraVit 25 Ga+, 27 mm, Alcon). Stratified randomization was performed to balance the proportion of eyes with AL >28 mm between groups.
Main Outcome Measures
Trocar removal rate and core vitrectomy time were assessed as primary outcomes, and instrument bending as a secondary outcome. Anatomical and visual outcomes and complications were documented for 6 months. Subgroup analysis was performed to compare the eyes with AL >28 mm to those without.
Results
We included 86 patients with a mean age of 60.7 ± 9.6 years and an AL of 29.15 ± 2.14 mm. Two groups had comparable core vitrectomy times (−0.5 minutes, P = 0.172). The study group had a lower trocar removal rate (5% vs. 67%, P < 0.001) but a higher instrument bending rate (36% vs. 14%, P = 0.036), particularly in eyes with AL >28 mm. In eyes with AL >28 mm, the standard vitrectomy probe faced a significantly greater difficulty in cortical vitreous removal, internal limiting membrane (ILM) trimming, or posterior vitreous detachment induction compared with the long-shaft vitrectomy (P < 0.001). At 6 months, significant visual improvement (logarithm of the minimum angle of resolution) and anatomical success were achieved (study: −0.22, 95%; control: −0.24, 88%). Eyes with ERM in the study group, not the controls, had significant visual improvement (−0.21, P = 0.02 vs. −0.09, P = 0.34).
Conclusions
The long-shaft vitrectomy probe is safe and efficient, especially in highly myopic eyes with AL >28 mm, despite a higher instrument bending rate. It provides improved access to the posterior pole, allowing for delicate removal of adherent cortical vitreous and trimming of ILM flaps. Addressing increased instrument bending due to the sleeveless design is important for future design.
Financial Disclosure(s)
The author(s) have no proprietary or commercial interest in any materials discussed in this article.